Tofacitinib exposure across 2 pregnancies in alopecia universalis: Case report and literature review of Janus kinase inhibitors in pregnancy. [PDF]
Alajlan A +5 more
europepmc +1 more source
A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme. [PDF]
Hernández Arroyo J +2 more
europepmc +1 more source
The dose matters: Oral tofacitinib dose escalation or switching to deuruxolitinib for recalcitrant alopecia universalis and totalis, a retrospective case series. [PDF]
Ezzat RZ, Paz M, Kreytak C, Senna MM.
europepmc +1 more source
Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata. [PDF]
Kołcz K +3 more
europepmc +1 more source
Evaluation of Effectiveness of Bio-Micro Injection in Treating Alopecia Universalis: A Non-Randomized Interventional Study : Mesotherapy in Treating Alopecia Universalis. [PDF]
Shirzad S, Miladi M.
europepmc +1 more source
Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib. [PDF]
Lv X +11 more
europepmc +1 more source
Alopecia universalis following human papillomavirus vaccine administration: a case report. [PDF]
Wu Y, Liu X, Qiao J, Fang H.
europepmc +1 more source
Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report. [PDF]
Bhardwaj S +4 more
europepmc +1 more source
Autoimmune Polyglandular Syndrome Type 2 Presentation with Alopecia Universalis, Hashimoto's Disease, and Addison's Disease. [PDF]
Sales-Morales KD +3 more
europepmc +1 more source

